By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
AI’s Next Trillion-Dollar Market Isn’t Software | Max Jaderberg, President of Isomorphic Labs
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Great conversations run long. Their best ideas don't have to.
uListen is free on iPhone, iPad, Android, Chrome, and Claude.
See howEpisode Details
EPISODE INFO
- Released
- November 10, 2026
- Duration
- 43m
- Channel
- Silicon Valley Girl
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
AI can generate thousands of ideas. I asked Max Jaderberg how to tell which ones are worth pursuing. 📌 Bring your team’s research, context, and AI workflow together on one canvas: Try Miro - https://miro.pxf.io/E0XA34 📩 Follow my Newsletter (Future Proof): https://siliconvalleygirl.beehiiv.com/p/7-skills-that-make-you-irreplaceable-adc6?utm_source=youtube&utm_medium=description&utm_campaign=futureproof-sub&utm_content=7-skills&utm_term=max-jaderberg In this episode, I talked to Max Jaderberg, a former Google DeepMind research lead who helped develop AlphaFold 3 and is now president of Isomorphic Labs. He explains how his team uses AI to pick 20 or 50 molecules to test in the lab instead of screening hundreds of thousands, and what it takes to turn a promising molecule into a medicine. We talk about why Max hires AI engineers without a biology background, the interview question he uses to see how they learn, and how he turns a big mission into goals his team can measure. He also shares how to tell if an AI agent is improving your work and how to develop what he calls “research taste” so you can choose which problems are worth solving. Timestamps: 00:00 — Intro 03:02 — Why Developing a Drug Can Take 10 Years 05:38 — How AI Helps Scientists Design New Medicines 10:22 — How to Tell When AI Is Ready for Real Work 13:12 — How to Turn a Big Mission Into Measurable Goals 16:58 — Where the Next AlphaFold Moment Could Happen 19:00 — How to Tell if You Have the Right Data for AI 20:55 — Why Max Hires AI Engineers Without a Biology Background 23:09 — The Interview Question Max Uses to See How You Learn 24:45 — How AI Narrows the Search to 20 or 50 Molecules 26:58 — What Researchers Do When AI Comes Up With the Ideas 28:29 — Max’s Personal AI Stack 29:30 — Inside a Drug Design Agent That Runs for Days 30:46 — How to Tell if an AI Agent Is Worth Using 32:22 — The Part of His Job Max Keeps Human 33:17 — Why Promising Drugs Still Fail in Clinical Trials 35:58 — When AI-Designed Drugs Could Reach Pharmacies 40:14 — What to Learn if You Want to Work in AI for Science *📌 Help shape what’s next on Silicon Valley Girl!* Take our quick survey: https://docs.google.com/forms/d/e/1FAIpQLSdQEqUy3wiE7TlzM_haWLEcgV8eJUeSBIVaK2QjDsAVEsXm3w/viewform?usp=publish-editor Links: 🔗 My Instagram: https://www.instagram.com/siliconvalleygirl/ 𝕏 : https://x.com/siliconvalleymm 💼 LinkedIn: https://www.linkedin.com/in/marinamogilko 📌 My Companies & Products: https://partnerships.marinamogilko.co #SiliconValleyGirl #Podcast
SPEAKERS
Max Jaderberg
guestPresident of Isomorphic Labs and AI researcher (ex-DeepMind), focused on applying deep learning to drug discovery.
Marina Mogilko
hostHost of Silicon Valley Girl, interviewing founders and tech leaders about startups, AI, and innovation.
EPISODE SUMMARY
In this episode of Silicon Valley Girl, featuring Max Jaderberg and Marina Mogilko, AI’s Next Trillion-Dollar Market Isn’t Software | Max Jaderberg, President of Isomorphic Labs explores How Isomorphic Labs uses AI agents to redesign drug discovery Max Jaderberg explains how AlphaFold built confidence that AI can generalize in biology and chemistry, enabling Isomorphic Labs’ mission to redesign how medicines are made.
RELATED EPISODES